Roche halts diabetes drug trial in blow to pipeline and side effects; Great news to Mannkind
Roche halts diabetes drug trial in blow to pipeline; Great news to Mannkind.
The only company close to develop ultra fast diabetic product is MannKind. Even though BIOD and NVO are trying to make the similar products they are in the early stages, it can take about 2 to 4 years for development. So there is only just one Winner. This will go up considerably if the results are good.
IF you want to read the article cut and paste the head line and search in google.
I saw this news yesterday evening and it seems to be very promising for Mannkind, no wonder more institutional buyers in the roll, if you look at yesterday's pattern over a million dollar block buying is a prime example of Mannkind in action.